Minimizing disability: An overview of the pervasiveness, clinical manifestations and treatment of depression in Parkinson's disease

Journal of Pharmacy Practice

Volumn 21, Issue 4, 2008, Pages 273-277

  Larsen, Susan M ^a   Dashtipour, Khashayar ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; Depression; Parkinson's disease

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; MOOD STABILIZER; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY; ARTICLE; BALANCE DISORDER; BRADYKINESIA; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONSTIPATION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISABILITY; DYSTHYMIA; HELPLESSNESS; HOPELESSNESS; HUMAN; MAJOR DEPRESSION; MEMORY DISORDER; MENTAL HEALTH; MUSCLE RIGIDITY; PARKINSON DISEASE; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR RETARDATION; SENSORY DYSFUNCTION; SOCIAL WORK; SUICIDAL IDEATION; TREMOR;

EID: 47649100181     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190008318371     Document Type: Article

References (13)

1. Coffey CE, Cummings JL Parkinson's disease and parkinsonism. In: Textbook of Geriatric Neuropsychiatry. Washington, DC: American Psychiatric Press ; 1994: 434-456.
2. Hubble JP, Koller WC The parkinsonian personality. Adv Neurol. 1995 ; 65: 43-48.
3. Sano M., Stern Y., Williams J., et al. Coexisting dementia and depression in Parkinson's disease. Arch Neurol. 1989 ; 46: 1284-1286.
4. Mayeux R., Stern Y., Rosen J., et al. Depression intellectual impairment, and Parkinson disease. Neurology. 1981 ; 31: 645-650.
5. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR 4 th ed. Text Revised). American Psychiatric Association Press ; Washington, DC ; 2000.
6. Brown RG, MacCarthy B., Jahanshahi M., et al. Accuracy of self-reported disability in patients with parkinsonism. Arch Neurol. 1989 ; 46: 955-959.
7. Taylor A., Saint-Cyr JA, Lang AE, et al. Parkinson's disease and depression: a critical re-evaluation. Brain. 1986 ; 109: 279-292.
8. Huber SJ, Paulson GW, Shuttleworth EC Depression in Parkinson's disease. Neuropsychiatry. Neuropsychol Behav Neurol. 1988 ; 1: 47-51.
9. Rondot P., de Recondo J., Coignet A., et al. Mental disorders in Parkinson's disease after treatment with L-dopa. Adv Neurol. 1984 ; 40: 259-269.
10. Gotham AM, Brown RG, Marsden CD Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry. 1986 ; 49: 381-389.
11. Oyebode JR, Barker WA, Blessed G., et al. Cognitive functioning in Parkinson's disease: in relation to prevalence of dementia and psychiatric diagnosis. Br J Psychiatry. 1986 ; 149: 720-725.
12. Mindham RHS, Marsden CD, Parkes JD Psychiatric symptoms during L-dopa therapy for Parkinson's disease and their relationship to physical disability. Psychol Med. 1976 ; 6: 23-33.
13. Rogers D., Lees AJ, Smith E., et al. Bradyphrenia in Parkinson's disease psychomotor retardation in depressive illness: an experimental study. Brain. 1987 ; 110: 761-776.